Utsunomiya, Japan

Masakazu Murata

This inventor holds 1 USPTO granted patent. Top assignee: Kao Corporation. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masakazu Murata. Retrieved from https://idiyas.com/inventor/masakazu-murata-1u8pm5co

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masakazu Murata: Innovator in Hypertension Treatment

Introduction

Masakazu Murata is a notable inventor based in Utsunomiya, Japan. He has made significant contributions to the field of medical treatment, particularly in the management of hypertension. His innovative approach has garnered attention for its effectiveness and safety.

Latest Patents

Murata holds a patent for a preventive and therapeutic method for hypertension. This method involves dosing hexose phosphate calcium, which produces an immediate effect without undesirable side effects. It effectively controls rises in blood pressure and is beneficial for various diseases associated with hypertension, such as myocardial infarction, cerebral apoplexy, and cirrhosis of the liver.

Career Highlights

Masakazu Murata is affiliated with Kao Corporation, where he continues to work on advancements in medical treatments. His dedication to innovation in healthcare has positioned him as a key figure in the industry.

Collaborations

Murata has collaborated with notable coworkers, including Yoshinao Nagashima and Kenji Hara. Their combined expertise has contributed to the development of effective medical solutions.

Conclusion

Masakazu Murata's work in hypertension treatment exemplifies the impact of innovative thinking in medicine. His contributions continue to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…